- Home
- TOL vs HOLX Comparison
TOL vs HOLX Comparison
Compare TOL & HOLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TOL
- HOLX
- Stock Information
- Founded
- TOL 1967
- HOLX 1985
- Country
- TOL United States
- HOLX United States
- Employees
- TOL N/A
- HOLX N/A
- Industry
- TOL Homebuilding
- HOLX Medical Electronics
- Sector
- TOL Consumer Discretionary
- HOLX Health Care
- Exchange
- TOL Nasdaq
- HOLX Nasdaq
- Market Cap
- TOL 13.8B
- HOLX 16.5B
- IPO Year
- TOL N/A
- HOLX 1990
- Fundamental
- Price
- TOL $135.77
- HOLX $74.64
- Analyst Decision
- TOL Buy
- HOLX Hold
- Analyst Count
- TOL 15
- HOLX 15
- Target Price
- TOL $150.87
- HOLX $79.64
- AVG Volume (30 Days)
- TOL 967.3K
- HOLX 5.0M
- Earning Date
- TOL 12-08-2025
- HOLX 11-03-2025
- Dividend Yield
- TOL 0.74%
- HOLX N/A
- EPS Growth
- TOL N/A
- HOLX N/A
- EPS
- TOL 13.61
- HOLX 2.49
- Revenue
- TOL $10,876,787,000.00
- HOLX $4,100,500,000.00
- Revenue This Year
- TOL $0.45
- HOLX $6.23
- Revenue Next Year
- TOL N/A
- HOLX $5.37
- P/E Ratio
- TOL $9.98
- HOLX $29.94
- Revenue Growth
- TOL 3.26
- HOLX 1.74
- 52 Week Low
- TOL $86.67
- HOLX $51.90
- 52 Week High
- TOL $169.52
- HOLX $80.31
- Technical
- Relative Strength Index (RSI)
- TOL 52.12
- HOLX 72.62
- Support Level
- TOL $131.00
- HOLX $74.07
- Resistance Level
- TOL $135.13
- HOLX $74.28
- Average True Range (ATR)
- TOL 3.54
- HOLX 0.23
- MACD
- TOL 0.03
- HOLX -0.12
- Stochastic Oscillator
- TOL 48.27
- HOLX 95.06
About TOL Toll Brothers Inc.
Toll Brothers is the leading luxury homebuilder in the United States with an average sale price well above public competitors'. The company operates in over 60 markets across 24 states and caters to move-up, active-adult, and second-homebuyers. Traditional homebuilding operations represent most of company's revenue. Toll Brothers also builds luxury for-sale and for-rent properties in urban centers across the US. It has its headquarters in Horsham, Pennsylvania.
About HOLX Hologic Inc.
Hologic manufactures proprietary products for the healthcare needs of women. The company operates in four segments: diagnostics (44% of total sales), breast health (38%), surgical (16%), and skeletal health (2%). While the company traditionally focused on breast health, the acquisition of Gen-Probe put greater emphasis on commercial diagnostics. The United States accounts for the largest portion of the firm's revenue (69%), followed by Europe (20%), Asia (8%), and other international markets (3%). Hologic is headquartered in Bedford, Massachusetts.